Brain Tumor
353
73
97
149
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
34 trials with published results (10%)
Research Maturity
149 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.2%
29 terminated out of 353 trials
83.7%
-2.8% vs benchmark
8%
27 trials in Phase 3/4
23%
34 of 149 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 149 completed trials
Clinical Trials (353)
Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Neurocognitive Assessment CNSL and LGG
Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated With Cranial Radiation for Brain Tumors
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
Mapping of Human Cognition
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Asciminib With or Without Sildenafil for Brain Tumors
Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
FIH Clinical Investigation of Graphene Electrodes for Brain Mapping
Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas